Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma

Jardin, Fabrice, Bastard, Christian, Contentin, Nathalie, Parmentier, Françoise, Picquenot, Jean-Michel, Tilly, Hervé, Stevenson, Freda K. and Sahota, Surinder S. (2003) Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma. Blood, 102 (5), 1872-1876. (doi:10.1182/blood-2002-12-3630).

Abstract

Translocations and somatic mutations are common genetic alterations of the BCL-6 gene on chromosome 3q27 in B-cell lymphoma, with implications for lymphomagenesis. The 2 events may have linked origins and can influence juxtaposed loci. To evaluate this further, we compared mutations occurring within the major mutation cluster region of the translocated and untranslocated BCL-6 alleles in 7 t(3;14)(q27;14q32) lymphomas. In 6 of 7 cases, the translocated allele revealed significantly higher mutations (mean, 5.8 x 10–2 bp–1) than did the untranslocated allele (mean, 5.3 x 10–3 bp–1; P < .01). The increase mapped to der(14q32), which retains the BCL-6 promoter and is transcriptionally active, as revealed by fusion transcripts and ongoing somatic mutations, absent in the der(3q27) region. These results indicate that enhanced mutational activity at the translocated allele may be a consequence of loss of cis regulatory elements or gain of IgH enhancer elements. Junctional sequences indicate translocation origins from earlier BCL-6 mutations and switch recombinase events.

This record has no associated files available for download.

Contributors

Author: Freda K. Stevenson

Download statistics